Archives: Agenda
Session reserved for event sponsor
OPENING KEYNOTE Preparing for the MHRA’s Proposed Rare Disease Therapies Regulatory Framework – What Sponsors Need to Know
- The proposed framework
- Impact on rare disease developers
- Practical implications
- Questions from sponsors
Reserved for NIHR
Chairperson’s opening remarks
The AI-first enterprise: a roadmap from strategy to scaled deployment
- What the most advanced institutions are doing differently: lessons from AI programmes delivering at enterprise scale
- Sequencing the journey: foundations, first wins, scaling and continuous improvement
- Preparing for what comes next: agentic AI, autonomous operations and the changing shape of the technology stack
Bridging the skills gap
- Upskilling at scale: building AI literacy across the whole organisation, not just the technology function
- The new roles emerging in the AI-enabled enterprise, from prompt engineers to AI product owners
- Competing for scarce talent: recruitment, retention and the case for growing your own
- Redesigning roles and career paths as AI reshapes the day-to-day work of your teams
Overcoming barriers to AI implementation
- Navigating the real-world blockers: legacy technology, data silos, budget constraints and cultural resistance
- Securing stakeholder buy-in: bringing risk, compliance and the front office along on the journey
- Managing vendor relationships and avoiding lock-in as the market evolves at pace
- How to fail fast, learn quickly and keep momentum when projects hit turbulence
Chairperson’s Opening Remarks
Gala Dinner 社交晚宴
Forging a World-Class Hub of Biomedical Innovation 打造世界级生物医药创新高地
- Development of the biomedical industry in SIP
- Innovation ecosystem for biomedical industry in SIP
- 苏州工业园区(SIP)生物医药产业的发展历程与现状
- 苏州工业园区(SIP)生物医药产业的创新生态系统